# A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors

Source: https://onco.cc/trials/nct06223841/  
OnCo record `nct06223841` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of IAP0971 in advanced solid tumours, run by SUNHO（China）BioPharmaceutical CO., Ltd., now recruiting.

## Summary

A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors is a phase 1/2 interventional study registered as NCT06223841 by SUNHO（China）BioPharmaceutical CO., Ltd., with 50 participants planned, started 2024-03-01 and due to reach its primary completion in 2026-03-01. Interventions recorded: IAP0971.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06223841
- Phase: 1/2
- Setting: A Clinical Trial of Phase Ib/II to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors
- Sponsor: SUNHO（China）BioPharmaceutical CO., Ltd.
- Enrolled: 50

## Sources

- ClinicalTrials.gov NCT06223841: https://clinicaltrials.gov/study/NCT06223841

## Connected records

- cancers: [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/)

---
JSON: https://onco.cc/api/v1/entities/nct06223841.json